- Published at
- by insidermonkey.com
mixed
mixed
Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript
Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is $0.59, expectations were $-0.86. Emergent BioSolutions Inc.
News for Emergent Health Corp (EMGE)
- Published at
- by investing.com
mixedmixedEarnings call: Emergent BioSolutions raises 2024 profit outlook By Investing.com
Earnings call: Emergent BioSolutions raises 2024 profit outlook- Published at
- by seekingalpha.com
mixedmixedEmergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript
Emergent BioSolutions Inc. (NYSE:NYSE:EBS) Q1 2024 Earnings Call Transcript May 1, 2024 5:00 PM ETCompany ParticipantsJoe Papa - President and CEORich...- Published at
- by globenewswire.com
positivepositiveBioRestorative Therapies Enters into Supply Agreement with Evolutionary Biologics
--BioRestorative to Leverage its Core Competencies in Cell Biology and Manufacturing to Supply Biologics for Cosmetic Applications in Strategic Agreement ...- Published at
- by globenewswire.com
positivepositiveNutraLife Biosciences (OTC: NLBS) Releases Q4 2022 Shareholder Update
NutraLife, manufacturer, and distributor of branded nutraceutical and skincare products, is pleased to provide a shareholder update COCONUT CREEK,...- Published at
- by globenewswire.com
mixedmixed- Published at
- by globenewswire.com
positivepositiveNutralife Biosciences Executes a Joint Venture Agreement With Emergent Health Corporation for the Co-Production, Co-Marketing, and Distribution of Emergent’s Line of Regenerative, and Other Health-Rel
COCONUT CREEK, FL, July 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – NutraLife Biosciences Inc. (OTC: NLBS), a manufacturer and distributor of private...